Navigation Links
'A little off the top' helps NIST map cells with submicrometer resolution
Date:3/2/2011

To determine if a tissue biopsy reveals the presence of cancer, a histologist often screens for cells with an abnormal appearance or a specific visible trait such as a larger-than-usual nucleus. However, by the time a cancer is physically noticeable, the disease may be in its later stages and more difficult to treat. In an effort to identify the earlier-onset, more subtle chemical changes occurring in a cell heading toward malignancy, researchers at the National Institute of Standards and Technology (NIST) and the National Cancer Institute (NCI) have developed a technique that slices off the top of a cell and makes the structures accessible to spectroscopic examination of their chemical "signature."

Secondary-ion mass spectrometry (SIMS) is a laboratory method developed in the 1960s to define and map the chemicals making up a substance or structure. An ion beam is shot at the surface of a sample, knocking chemical species off the target area that can then be identified by a mass spectrometer. The resulting spectra, in turn, can be used to create a chemical map of the sample.

To date, using SIMS imaging to map mammalian cells has yielded only modest success. To get to the interesting stuff inside the cell, the beam must first blast away the outer cell membrane. Like using a pickax to uncover a fossil, the beam often digs unevenly or too deeply and can damage or destroy the complex molecules and structures inside. The NIST/NCI team tried something more surgical. They first freeze-dried the cell in a manner that prevented its membrane from rupturing and then gently milled the top off the cell with a more powerful, more precisely controlled focused ion beam (FIB) that can skim across the cell at a specified depth. The interior of the cell is left exposed and as close to its natural state as possible for the SIMS beam. "In effect, we get a new, extremely data-rich surface for analysis," says team leader Christopher Szakal.

In a recently published proof-of-concept experiment,* the NIST/NCI researchers applied their method to samples from the HeLa immortal human cancer cell line. Specific chemical signals were mapped across the region sliced open by the FIB, yielding images of the cell structures they define at resolutions better than a micrometer (millionth of a meter). For example, spectral maps of phospholipids were used to produce two-dimensional views of cell membranes.

The next step, Szakal says, is to show that the FIB can cleanly slice more than just the top layer off of a cell. "If we can use the FIB-SIMS method to chemically map successive layers of a cell, we'll be able to get three-dimensional images of the cell's components," he explains.

Additionally, the NIST/NCI team is developing mathematical algorithms to enhance and improve the images produced by its new system. The researchers hope that the technique will eventually enable diagnosticians to spot early changes in cell structure that could indicate a move toward abnormality (such as an enlargement of the nuclear membrane) or detect the initial presence of biomarkers, chemical species that can potentially be used to monitor the growth of specific cancers.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology news :

1. Modest CO2 cutbacks may be too little, too late for coral reefs
2. Beetles get by with a little help from their friends
3. Sarcospan, a little protein for a big problem
4. A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart
5. Spider love: Little guys get lots more
6. Just a little squeeze lets proteins assess DNA
7. New World post-pandemic reforestation helped start Little Ice Age, say Stanford scientists
8. Researchers advance knowledge of little nano-machines in our body
9. Little Salt Spring underwater archeological site in Florida receives new funding
10. A little java makes it easier to jive, researcher says
11. Hush little baby... Linking genes, brain and behavior in children
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'A little off the top' helps NIST map cells with submicrometer resolution
(Date:12/16/2016)... Dec 16, 2016 Research and Markets has ... - Global Forecast to 2021" report to their offering. ... The biometric vehicle ... at a CAGR of 14.06% from 2016 to 2021. The market ... projected to reach 854.8 Million by 2021. The growth of the ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 19, 2017 , ... ... pharmaceutical research and development (R&D), today announced the launch of Data ... interpretation for the rapidly evolving field of precision medicine. , Data ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical ... update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data ... the existing policy. AMIA recommended that NIH earmark funding for researchers to produce ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
Breaking Biology Technology: